| Literature DB >> 33875932 |
Colin Fuller1,2, Andre' M Wineland1,2, Gresham T Richter1,2.
Abstract
PURPOSE OF REVIEW: Tracheostomy in a child demands critical pre-operative evaluation, deliberate family education, competent surgical technique, and multidisciplinary post-operative care. The goals of pediatric tracheostomy are to establish a safe airway, optimize ventilation, and expedite discharge. Herein we provide an update regarding timing, surgical technique, complications, and decannulation, focusing on a longitudinal approach to pediatric tracheostomy care. RECENTEntities:
Keywords: Bronchopulmonary Dysplasia; Clinical Reviews; Pediatrics; Trachea; Tracheostomy
Year: 2021 PMID: 33875932 PMCID: PMC8047564 DOI: 10.1007/s40136-021-00340-y
Source DB: PubMed Journal: Curr Otorhinolaryngol Rep
Fig. 1Proposed timeline for the care of the patient undergoing non-emergent tracheostomy, from the initial hospitalization through decannulation. Single asterisk “*: Transition off of mechanical ventilatory support is a process of variable length and can take years in younger patients with severe bronchopulmonary dysplasia. Double asterisk “**”: Pre-decannulation studies can include polysomnogram and/or upper and lower airway endoscopy
Recent publications, pediatric post-tracheostomy mortality
| Primary author, year | Design | Specific pediatric population | Risk factors for mortality | Mortality rate (timeframe) | Tracheostomy-related mortality rate (timeframe) | |
|---|---|---|---|---|---|---|
| Watters, 2016 [ | 502 | Retrospective cohort | Medicaid pts < 16 y/o | Hispanic, younger age at tracheostomy | 9.0% (2 year) | - |
| Funamura, 2016 [ | 513 | Retrospective cohort | - | Older age, BPD, CHD, infection, neoplasia, chronic mechanical ventilation, tracheostomy prior to 2010 | 16.6% (indefinite) | 3.5% (indefinite) |
| Tsuboi, 2016 [ | 212 | Retrospective cohort | PICU patients, neurologically impaired vs intact | Neoplasia | 14% (1 year), 29% (5 year) | 1.9% (indefinite) |
| Dal’Astra, 2017* [ | 5933 | Meta-analysis, stratified by decade of publication | - | - | 10.6% (various) | 0.9% (various) |
| McPherson 2017 [ | 426 | Retrospective cohort | PICU patients | Acquired neurologic, congenital neurologic, and congenital respiratory comorbidities | 23% (indefinite) | - |
| Rizzi, 2017 [ | 29 | Case series | Severe OSA indicating tracheostomy | - | 0% (indefinite) | 0% (indefinite) |
| Prodhan, 2017 [ | 126 | Retrospective cohort | History of HLHS | - | 26% (indefinite) | - |
| Rawal, 2019 [ | 543 | Retrospective cohort | Stratified by weight at surgery (< 2.5 kg, 2.5–4 kg, > 4 kg) | - | 4.3% (30 day) | - |
| Han, 2020 [ | 3442 | Prospective cohort | Neonates with very low birthweight, stratified by birthweight | Birth weight < 750 g, male sex, CLD, neurologic comorbidity, cardiac comorbidity, chromosomal comorbidity | 18.5% (1 year in-hospital mortality rate) | - |
| Friesen, 2020 [ | 14,155 | Retrospective cohort | All pediatric patients in the PHIS database | Younger age, Asian, Northeast region, cardiac, hematologic, metabolic, urologic comorbidities, prematurity | 8.6% (pre-discharge mortality rate) | - |
Summary of mortality rates in studies published since 2016
*Data from the most recent era (2005–2014) are here reported. N, number of patients in the cited study; pts, patients; y/o, year old; BPD, bronchopulmonary dysplasia; CHD, congenital heart disease; PICU, pediatric intensive care unit; OSA, obstructive sleep apnea; HLHS, hypoplastic left heart syndrome; kg, kilogram; CLD, congenital lung disease; PHIS, pediatric health information system
Recent publications, pediatric decannulation protocols
| Primary author, year | Patient population | Standardized decannulation protocol | Inpatient nights required (if specified) | Failure rate (first decannulation, if multiple) | Risk factors for failure | |
|---|---|---|---|---|---|---|
| Cristea, 2016 [ | < 18 y/o | 210 | Admission MLB or sleep endoscopy; decannulation in sleep lab with immediate PSG; formal PSG | 1 | 20.4% | |
| Lee, 2016 [ | < 18 y/o | 30 | Downsize to 3-mm tube; awake capping; admission with overnight pulse oximetry; formal capped PSG; decannulation; discharge | 2 | 13.3% | |
| Beaton, 2016 [ | < 18 y/o | 45 | MLB; trach tube downsize; trach tube capping; decannulation; overnight observation; discharge | 4 | 44.5% | - |
| Banyopadhyay, 2016 [ | < 18 y/o | 189 | MLB with temporary decannulation; admission with decannulation and immediate PSG; overnight PSG; discharge | 1 | 22.2% | Prematurity, decannulation based on parental expectations of success, dysphagia, craniofacial/genetic comorbidities, hydrocephalus, BPD |
| Wirtz, 2016 [ | < 18 y/o | 35 | Sleep endoscopy ± MLB with temporary decannulation; PICU admission with decannulation; discharge | 1+ | 5.7% | - |
| Maslan, 2017 [ | < 18 y/o | 46 | No fixed protocol, most underwent MLB and PSG | Variable | 2.1% | - |
| Pozzi, 2017 [ | < 18 y/o in inpatient rehab | 68 | Inpatient capping trials with continuous pulse oximetry; fiberoptic laryngoscopy; selective PSG only | N/A (inpatient for rehab) | 0% | |
| Seligman, 2019 [ | 0–5 y/o | 26 | MLB; change to fenestrated trach tube when awake; inpatient overnight pulse oximetry; decannulation; half-day pulse oximetry; discharge | 1 | 15.3% | - |
| Morrow, 2019 [ | 0–21 y/o with brain or spinal cord injuries who underwent PSG for decannulation | 38 | Capped PSG during inpatient stay; selective airway endoscopy | N/A (inpatient for rehab) | 0% | - |
Summary of decannulation studies published since 2016. N, number of patients in the cited study; y/o, years old; MLB, microlaryngoscopy and bronchoscopy; PSG, polysomnogram; BPD, bronchopulmonary dysplasia; N/A, not applicable